Weight loss drug Wegovy will soon be available in Canada, starting May 6. This announcement was made by the pharmaceutical company Novo Nordisk on Thursday.
Wegovy, also known as semaglutide, is a once-weekly injection that has been approved by Health Canada for chronic weight management in adults with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.
According to Novo Nordisk, Wegovy has been shown to help patients lose an average of 15% of their body weight in clinical trials. This is significantly higher than other weight loss medications currently available in Canada.
The drug works by mimicking a hormone called GLP-1, which helps regulate appetite and food intake. It also slows down the movement of food through the stomach, making patients feel fuller for longer periods of time.
Wegovy has been available in the United States since June 2020 and has been met with positive reviews from patients and healthcare professionals. It is expected to have a similar impact in Canada, where obesity rates continue to rise.
According to Statistics Canada, over 26% of Canadian adults are considered obese, and this number is expected to increase in the coming years. Obesity is a major risk factor for chronic diseases such as heart disease, stroke, and type 2 diabetes.
The availability of Wegovy in Canada provides a new option for individuals struggling with obesity and its associated health risks. However, it is important to note that the drug is not a magic solution and should be used in conjunction with a healthy diet and exercise.
Wegovy will be available by prescription only and will be covered by most private insurance plans. Patients interested in trying the drug should consult with their healthcare provider to determine if it is the right option for them.
In conclusion, the arrival of Wegovy in Canada offers hope for those struggling with obesity and its related health issues. With its proven effectiveness and availability, it is a promising addition to the options available for weight management.
